SEPTRA GRAPE Drug Patent Profile
✉ Email this page to a colleague
When do Septra Grape patents expire, and when can generic versions of Septra Grape launch?
Septra Grape is a drug marketed by Monarch Pharms and is included in one NDA.
The generic ingredient in SEPTRA GRAPE is sulfamethoxazole; trimethoprim. There are twenty-seven drug master file entries for this compound. Forty-nine suppliers are listed for this compound. Additional details are available on the sulfamethoxazole; trimethoprim profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Septra Grape
A generic version of SEPTRA GRAPE was approved as sulfamethoxazole; trimethoprim by SUN PHARM INDUSTRIES on August 25th, 1986.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for SEPTRA GRAPE?
- What are the global sales for SEPTRA GRAPE?
- What is Average Wholesale Price for SEPTRA GRAPE?
Summary for SEPTRA GRAPE
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| Raw Ingredient (Bulk) Api Vendors: | 22 |
| Clinical Trials: | 23 |
| DailyMed Link: | SEPTRA GRAPE at DailyMed |
Recent Clinical Trials for SEPTRA GRAPE
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| Roswell Park Cancer Institute | Phase 4 |
| National Cancer Institute (NCI) | Phase 4 |
| Cidara Therapeutics Inc. | Phase 3 |
US Patents and Regulatory Information for SEPTRA GRAPE
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Monarch Pharms | SEPTRA GRAPE | sulfamethoxazole; trimethoprim | SUSPENSION;ORAL | 017598-002 | Feb 12, 1986 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
